TGen News & Press Releases

TGen News & Press Releases

Circulating Tumor DNA Guides Chemotherapy Use in Stage II Colon Cancer

Posted Saturday June 4, 2022

Researchers from TGen, a part of City of Hope, contribute to study supporting value of ctDNA in assessing treatment options

TGen study offers path for late-stage cancer patients wanting to leverage their own health data to guide their care

Posted Wednesday May 18, 2022

Prev
[1]
Next

Media Contact

Galen Perry
[email protected]
602-343-8423

Newsletter

News Archive

View Media Release Archive

OnCline

TGen is a partner with OncLive

2022 © All Rights Reserved TGen. Registered 501(c)(3). EIN: 75-3065445